2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)esophageal adenocarcinoma, gastroesophageal cancerActive, not recruitingPhase 32026-02-27NCT06356311
Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016)neoplasmActive, not recruitingPhase 22025-04-06NCT04976634